chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/10/22 significant hypertension diagnosed during unrelated orthopedic visit:  193/108.   Bought an at-home BP monitor and followed up with high BP readings on 1/17 and 1/18/22:  187/100,  205/94;   after 200/95 on 1/19/22, unable to reach primary care provider, so I went to the local ER:  219/109.   No chest pain or headache, no symptoms of stroke.  Started Amlodipine 5mg,  increased to 10mg on 1/31/22 with BP gradually coming down, highest 169/83.  Current range:  126/76 to 148/78.
This case was reported by a pharmacist and described the occurrence of decreased therapeutic response in an adult female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). On unspecified date(s) the subject received unspecified dose(s) of ENGERIX B (0.5 ml, details unknown). On an unknown date after vaccination with unspecified dose(s) of ENGERIX B, the subject experienced decreased therapeutic response. The pharmacist reported that the subject was a new physician in her health system and had received her Hepatitis B vaccine at an unknown time prior to coming to the facility. The subject completed the series "some time ago". The subject recently had a child and her titers were checked after the birth of her child. When her titers were recently checked, they were low. There was no further information provided.
aching muscles-shoulders, lower back & legs;rash on arms, legs & torso;13JAN97 pt stated exp joint pain & swelling;c/o diff ambulating;advised by MD to see PMD;
Child given a Booster of Moderna instead of 1st dose pediatric Pfizer vaccine.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On an unknown date, the patient was vaccinated with the dose of GARDASIL injection, lot # K011325, expiration date 08-APR-2017 (dose and route were not reported) that was improperly stored. The vaccine had 3 temperature excursions and was administered between the second and third. Product quality complaint was not involved. Additional information has been requested.
This spontaneous report as received from a patient's mother refers to a female patient of unknown age. On 15-FEB-2013 the patient was vaccinated with the first dose of GARDASIL, injection (strength, route, lot number and expiration date not provided). On 31-MAY-2013 the patient was vaccinated with the second dose of GARDASIL, injection (strength, route, lot number and expiration date not provided). On 19-AUG-2013 the patient was vaccinated with the third dose of GARDASIL, injection (strength, route, lot number and expiration date not provided). The reporter stated that her daughter received GARDASIL outside of the recommended dosing schedule. No adverse events were reported. Additional information is not expected.
MON 3/8/ NAUSEA AND CHILLS   HEADACHE OFF AND ON   TEMP 99   RIGHT ARM HURTS TUE 3/9      AM CHILLS SICK AT STOMACH  (7 PM THROWING UP) (GREEN STUFF)  DIARRHEA BAD    IN/OUT  BED MOST OF DAY      RIGHT ARM HURTS WED 9/10  GOT UP BUT WENT BACK TO BED FOR THE DAY  GOT UP 7:30 PM  NOT THROWING UP  HEADACHE OFF/ON   RIGHT ARM STINN HURTS
Around 48 HR after my booster, I noticed a white ring around injections site about 2" diameter that didn't hurt or itch I did not seek medical attention at that point. On November 16th, in the afternoon I started noticing cramping in my right leg. I contacted Dr. and she scheduled an Ultrasound 2 weeks later and they confirmed there were two DVTs One was inclusive and one was not. I was prescribed Xarelto currently 20MG per day. No follow ups are scheduled yet.
Immediately after getting the vaccine, the patient felt very lightheaded and weak.  She then developed localized redness and itching around the left deltoid injection site that spread up her arm and across her chest.  She felt like her throat was swolen too.  She went to ER shortly after getting the vaccine as she was still feeling funny and was given Benadryl, Pepcid, and Decadron.  She was discharged from the ER.  She returned to ER the following day due to continued allergic reaction despite taking more prescribed medications. She had continued erythema, tenderness and itching to the left arm which traveled across the chest and into the right upper arm.  She had a continued snse of swelling in her throat.  (She had a seasonal flu vaccine earlier this season that was without preservatives, so patient is thinking this is a reaction to the preservative).  This time she was given an additional prescription for topical Valisone ointment.  Because this patient is a hospital employee in our department, I further know that she experienced a lingering tingling and numbness feeling in her left arm (the injection site arm) that lasted about a week.
Patient described her reaction as having a redness/warm feeling  in the injection area the next day (on 9/30/2019) and then getting a fever on the third day  (10/1/2019).   Pt received care at urgent care/ER and got an antibiotic  for skin infection.  Per pt, she is better now since pt started the antibiotic. The redness in the injection area is decreasing per pt.
It started with a sore throat, a cough, nasal congestion, and chest congestion. I took a COVID-19 test on November 18th, and the result was negative. I then had a virtual visit on November 20th. They thought it might be an upper respiratory infection and prescribed me antibiotics.
FAST HEART RATE; FEVER; MUSCLE ACHE; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown) dose was not reported, administered on 06-APR-2021 at 11:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-APR-2021, at around 15:30 or 16:00, the patient experienced fever, muscle aches, headache, and a very fast heart rate of more than 160 (unit not provided). On 07-APR-2021, her heart rate was at 130-140. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, muscle ache, headache and fast heart rate was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210411783-covid-19 vaccine ad26.cov2.s-fast heart rate. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
I woke up at 7:30AM and couldn't stand up, it was in pain in my right hip and upper leg. Three days later I went to the ER because I couldn't walk, they thought it was a sialic nerve pinch so they gave me a steroid shot, hydrocortisone and a muscle relaxer (methocarbamol). I did a follow up appointment because the medicine didn't work and they found some arthritis. No other medicine was prescribed and I ended up going to physical therapy and it helped a lot.
Client  received the 2nd COVID vaccine (Moderna, Lot # 027C21A, EXP: 07/11/2021) at 18:45. Both EMT's on site reported to PHN on site of similar reaction to 1st dose of Moderna. At 18:46 Client  complains of "left arm getting tight/warm and swollen", after 5 minutes in observation, client's vitals were taken at the time of reported symptoms, blood pressure: 170/80, heart rate: 68, oxygen saturation 97%. Client mentions history of elevated blood pressure, allergy to ibuprofen, and stated "he forgot to take his daily medication." Per client previous symptoms with 1st Covid vaccine resolved and he did not take any medications or seek medical attention. Client is alert and oriented to person, place, time and date. Client denies nausea, chest pain, abdominal pain, shortness of breath, or any noticeable rashes or itchiness. At 18:52 vitals were taken; blood pressure 176/92, heart rate: 67, oxygen saturation 98%, Client requested an ice pack, ice pack given by EMT. Client stated "arm feels better with a cold compress and discomfort is improving." At 19:02 vitals were taken; blood pressure 170/94, heart rate: 71, oxygen saturation 97%, client continues to deny any other new symptoms, and stated "arm is improving". PHN on site advised client to follow up with primary care provider, offered EMS due to high blood pressure, client refused. PHN on site gave ER precautions. Client agreed and verbalized understanding about information. At 19:15 vitals were taken; blood pressure 152/84, heart rate: 72, oxygen saturation 97%, per client no new symptoms. At 19:19 client left facility with a steady gait.
generalized pain, confusion, unable to stand, falling,, low-grade fever, high blood pressure, increased pulse, malaise, decreased appetite.
No other AE/PQC reported; a dose of expired VAQTA was inadvertently given to a patient; This spontaneous report as received from a medical assistant refers to a 17-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.     On 21-JAN-2021, the patient was inadvertently vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # T001419, expiration date: 06-JAN-2021(formulation, strength, dose, frequency, route of administration were not reported) for prophylaxis. The hepatitis a vaccine, inactivated (VAQTA) had not had any prior temperature excursions. No adverse events were reported.
The following day after receiving the tetanus vaccine pt. developed redness in her left arm that has spread to her elbow. It is tender and warm on palpation. Saw PA-C in the ER Urgent care and was placed on Keflex mg 4 times a day for 7 days on 1/26/08.
doesn't  feel good; flu-like symptoms; very weak; mouth is very dry, like sticky, inside; watery diarrhea; pajamas were all wet/chest was wet; got worse and worse; fever; constant headache on the left side; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (doesn't  feel good), INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (pajamas were all wet/chest was wet), CONDITION AGGRAVATED (got worse and worse) and ASTHENIA (very weak) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Sep-2021, the patient experienced HEADACHE (constant headache on the left side). On 06-Sep-2021, the patient experienced HYPERHIDROSIS (pajamas were all wet/chest was wet), CONDITION AGGRAVATED (got worse and worse), DIARRHOEA (watery diarrhea) and PYREXIA (fever). On an unknown date, the patient experienced VACCINATION COMPLICATION (doesn't  feel good), INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (very weak) and DRY MOUTH (mouth is very dry, like sticky, inside). At the time of the report, VACCINATION COMPLICATION (doesn't  feel good), INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (pajamas were all wet/chest was wet), CONDITION AGGRAVATED (got worse and worse), ASTHENIA (very weak), DRY MOUTH (mouth is very dry, like sticky, inside), DIARRHOEA (watery diarrhea), HEADACHE (constant headache on the left side) and PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided No treatment medication were provided
Unspecified adverse event; This case was reported by a lawyer and described the occurrence of adverse event in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The initial information was received on 30 April 2020 via medical record. As per record the patient had prescribed with Shingrix 50MCG Injection intramuscular single dose vial, she administered 0.5ml in the muscle. On an unknown date, the patient experience unspecified event.
Pain; A spontaneous report was received from consumer, concerning Patient , of Unspecified age  Female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  pain in the same arm of the injection   The patient's medical history was not reported by a reporter.  On Unspecified Date to onset of events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection. and experienced  pain in the same arm of the injection  No Concomitant Medication was reported by reported.   No treatment information was provided.  Action taken with mRNA-1273 in response to events were not provided.
vaccine expiration date was 4-24-23, vaccine was given on 5-9-23. Coworker got vaccine ready and asked me to give it because she needed to take care of another patient.
(L) upper arm - medial erythema with increased temp of skin or lymphangitis - not around the site of injection.
Joint pain, muscle aches, pain at injection site, swollen axillary lymph nodes on same side as injection starting approx 8 hours after injection; additional symptoms following within the next 8 hours include fever, chills, GI upset (abdominal pain, nausea). Fever and chills resolved approx 36 hours following injection. Joint pain, muscle aches and GI upset persisted for approx 72 hours after onset, resolved approx 96 hours after injection.
WE WERE UNAWARE THAT THE CDC HAD CHANGED THE GUIDELINES FOR COVID VACCINATION AND THAT PFIZER MONOVALENT WAS NO LONGER AUTHORIZED.  WE DID NOT GET AN EMAIL ABOUT THE CHANGE UNTIL 4/24 AT 3 PM.
Case previously recorded as MA2009-4638. Case report received from a health care professional, on 17 NOV 2009. Patient under 4 years was vaccinated i.m. with one dose of S-OIV FLUVIRIN (batch no. unknown)in 2009. It was an out of label use because the patient was younger than 4 years. No adverse events were reported. Reference no.: NA09-008366.
redness and swelling at injection site, warm to touch, started as pink but grew deeper in color as time passed
10 minutes after receiving vaccines. Dad returned to my office reporting rash bilat on cheeks. Rash noted at nape of neck also rash varies in size not raised, small vesicle looking area in center. Observed x 15 minutes & rash subsided.
vomiting; brain fog; This spontaneous case was reported by a consumer and describes the occurrence of DISTURBANCE IN ATTENTION (brain fog) and VOMITING (vomiting) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced DISTURBANCE IN ATTENTION (brain fog). On an unknown date, the patient experienced VOMITING (vomiting). At the time of the report, DISTURBANCE IN ATTENTION (brain fog) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient has been diagnosed with Retinal Vein Occlusion in left eye.  No treatment has been obtained yet.  Symptoms are burning pain and blurred vision . Went to regular eye doctor on 5/172021, and was scheduled appointment that same day with specialist.  Has a follow up appointment on 6/25/20211.
fever of 101.8 (unit not reported); This is a spontaneous report from a contactable consumer reported for herself. This female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 31Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a fever of 101.8 (unit not reported) that initially did not improve with aspirin or Tylenol. Temperature is currently 100.6. The outcome of event was unknown.  Information on the lot/batch number has been requested.
15 YEARS OLD MALE PATIENT RECEIVED 0.2 ML OF KIDS PFIZER AGE 5 TO <12 Y
Pain at injection site, tenderness at injection site as well as in armpit of injection arm, Itching  and large red circular rash at injection site, fatigue, headache
3/19/03 (Day #14) c/o frontal HA's, neck pain (left and back side). Chills all nite-(didn't not take temp), could not get warm, knee pain (both from mid half to hip). Cold feet, extreme tiredness, shooting pain in both legs ankles to outside of thighs, like muscle pain. Took Tylenol PM on 3/19/03 and was able to sleep. 3/20/03 (Day 15) fever 101.1 at 8:45am. Left work at 10AM. Slept all day. PM fever broke, pain in neck gone. Slightly disoriented and stiff but able to eat in evening-feeling better. 3/21/03 (Day 16) feeling better. Back to work. Blood drawn for Parvovirus. HA's gone. Edema and redness on left ankle and lower leg noted. Pt associates this with yardwork he did on Sat. 3/15/03 when he was cutting down a Brazilian Pepper tree. Right leg and ankle looks good.
8/14/21: patient presents to ED with a chief complaint of dry cough, nausea, vomits since 7 days ago.  admitted. Tested positive for covid 8/14/21.  Note: patient previously vaccinated with Moderna vaccine: First dose: 03/16/21 Lot Number 030A21A;Second dose: 04/13/21 Lot Number 021B21A. Diagnosed with covid related viral pneumonia.  Discharged 8/23/21.
This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 09-JUL-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2014) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. Addtional information has been requested.
tachycardia; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 28 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TACHYCARDIA (non-serious), outcome "unknown", described as "tachycardia".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 61-year-old female patient received BNT162b2 (BNT162B2), on 02Apr2021 as dose 2, single (Lot number: PR8734) at the age of 60 years, in left arm for covid-19 immunization. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE1, Lot number: EP6955, Vaccine expiry date: Unknown), administration date: 12Mar2021, when the patient was 60-year-old, for COVID-19 immunization, reaction(s): "When caller received the other 3 doses, caller just had a sore arm.". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "When caller received the other 3 doses, caller just had a sore arm.".
After patient got home in the evening 10/25 after the flu shot, she noticed a rash on her arm. She reported a month later on 11/25 that the rash extended bilaterally from her arm to her feet. The rash itches. Denied any other symptoms of fever or breathing issue. Patient was referred to see a doctor about her rash symptoms.
After second vaccine, I experienced Fever, Chills, Headache, Nausea,Diarrhea,Generalized Weakness, Pain at injection site.  Lasted 17-18 hrs with lasting fatigue and headache into next day (1/13/21).  Tylenol and Advil were taken to help control fever and headache.
Achy body; fever - 101.3; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8727) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00 (at the age of 57-years-old) as a single dose for COVID-19 Immunisation. Medical history included high blood pressure. The patient did not have any allergy to medications, food or other products. The patient received prescribed medicine (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6203) via an unspecified route of administration on 02Mar2021 at 17:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient experienced fever of 101.3 (unit unspecified), chills and achy body. The patient received Tylenol as treatment for the events. The clinical outcome of the events fever 101.3, chills and achy body was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Systemic axn to anthrax vaccine required admission to hospital in early august.  He had fever, myalgias, angioedema, erythema multiforme.
On day 20 after vaccine, experienced chills, fatigue, muscle aches, GI pain (cramps).  Missed work on 2/25/21. Work from home until 3/3/21. Has appt. with PCP on 3/3/21.  Not sure the  symptoms are related to #2 vaccine.